Who invested in CoreMap

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 4 months ago

Funding summaryUpdated 26 Oct 2026

$57Mraised across 2 rounds since 2022, from 2 sources

$20MSeries B$37MSeries C

Latest round: Series C, $37MJul 2026
Step-upi: 1.9×
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20222023202420252026

$20MSeries B$37MSeries C

First round: Series B, $20M
Biggest round: $37M
Between rounds: 4.4 years

The rounds

Jul 2026
Series C$37M1 returning
- National Science Foundation
Source recordedSEC filing: $36M sold
Feb 2022
Series B$20M1 new
- National Science Foundation
Source recordedSEC filing: $23M sold, first sale Jan 2022

Founders and team

From CoreMap's own website: 1 founder, 6 on the team.

Sarah KalilCo-Founder, President, and CEO

Amanda FleuryVice President of Operations & Business Administration
Doron FeinsteinVice President of Research & Development
Christine GriggsHead of Finance
Koosha RafieeSystems Engineering Manager
Matt CremaAssociate Director of Data Science
Yao LiSenior Manager of Software Engineering

Everyone who backed them

National Science FoundationGovernment2rounds

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists CoreMap as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.